| 000 | 01550 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517163451.0 | ||
| 264 | 0 | _c20180326 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1535-5675 | ||
| 024 | 7 |
_a10.2967/jnmt.117.194571 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNia, Emily S | |
| 245 | 0 | 0 |
_aIncidence of Brain Metastases on Follow-up _h[electronic resource] |
| 260 |
_bJournal of nuclear medicine technology _cSep 2017 |
||
| 300 |
_a193-197 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aArizona _xepidemiology |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdiagnostic imaging |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aLung Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPositron Emission Tomography Computed Tomography _xmethods |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aGarland, Linda L | |
| 700 | 1 | _aEshghi, Naghmehossadat | |
| 700 | 1 | _aNia, Benjamin B | |
| 700 | 1 | _aAvery, Ryan J | |
| 700 | 1 | _aKuo, Phillip H | |
| 773 | 0 |
_tJournal of nuclear medicine technology _gvol. 45 _gno. 3 _gp. 193-197 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2967/jnmt.117.194571 _zAvailable from publisher's website |
| 999 |
_c27365955 _d27365955 |
||